Carcinoembryonic antigen (CEA) and mesothelin (MSLN) were highly expressed in pancreatic cancer, and dual-receptor CAR T cells targeting both antigens were found to target tumor sites precisely and reduce tumor load in pancreatic cancer mouse models (Figure 1C) (49). The gene discussed is CEACAM5; the disease is neoplasm.